Plasma calprotectin as a biomarker of mortality at antiretroviral treatment initiation in advanced HIV – pilot study [version 2; peer review: 2 approved]

Plasma calprotectin as a biomarker of mortality at antiretroviral treatment initiation in advanced HIV – pilot study [version 2; peer review: 2 approved]

Background: In advanced HIV, significant mortality occurs soon after starting antiretroviral treatment (ART) in low- and middle-incomes countries. Calprotectin is a biomarker of innate response to infection and inflammatory conditions. We examined the association between plasma calprotectin collecte...

Full description

Bibliographic Details
Main Authors: Faith W. Kamau, Agnes Gwela, Andrew K. Nyerere, Victor Riitho, James M. Njunge, Moses M. Ngari, Andrew J. Prendergast, James A. Berkley
Format: Article
Language:English
Published: Wellcome 2020-11-01
Series:Wellcome Open Research
Online Access:https://wellcomeopenresearch.org/articles/5-46/v2

Similar Items

Similar Items